What does PHARDEN do?

PHARDEN is a pharmacy in Bièvre. Public Limited, started on 18 February 1993, 1 establishment.

What is the address of PHARDEN?

The registered office of PHARDEN is located at Rue de Bouillon 17, 5555 Bièvre.

Is PHARDEN still active?

Yes. According to the CBE (29 October 2026) PHARDEN is active, legal situation “Normale toestand”, started on 18 February 1993.

Is PHARDEN registered on Peppol?

Yes, PHARDEN is registered on the Peppol network with ID 0208:0449472066.

What is the enterprise number of PHARDEN?

The enterprise number of PHARDEN is BE0449472066.

When was PHARDEN founded?

PHARDEN was founded on 18 February 1993.

Who are the directors of PHARDEN?

According to the 2025 annual accounts, the directors of PHARDEN are: CYRILLE REGNIER, Dr Pharma.

Is PHARDEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 February 1993; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARDEN make in 2025?

PHARDEN posted a profit after taxes of € 132,324 in financial year 2025.

What is the revenue of PHARDEN?

As a small company, PHARDEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 609,302.

How much does an employee at PHARDEN earn?

The average wage cost per full-time employee at PHARDEN was € 43,600 in 2025: staff costs of € 374,938 for 8.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARDEN have?

According to the 2025 annual accounts, PHARDEN has 8.6 full-time equivalents (FTE).

PHARDEN (Public Limited) - Bièvre - BE0449472066

Dossier PHARDEN, printed on 29 October 2026 from databakkes.be/en/0449472066/pharden. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 61 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARDEN from Bièvre, company number BE0449472066, closed financial year 2025 with a result of € 132,324 after tax. For that financial year PHARDEN recorded a gross margin of € 609,302 and equity of € 284,862. Compared with financial year 2024, the result moved from € 159,015 to € 132,324. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.

What it is worth Growing

€ 284,862

▲ 25% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 132,324

▼ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 243,835

▲ 69% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 75,000 paid out

57 % of the profit went to the shareholders, mostly to DR PHARMA (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

8.6

▼ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 374,938

▼ 4% vs 2024

€ 43,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 62,386

▲ 37% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 93,568

▼ 36% vs 2024

€ 40,939 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 367,293

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 73,379

▲ 11% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 487,226 Gross margin 2022: € 487,226 First fiscal year in the series	€ 596,023 Gross margin 2023: € 596,023 ▲ 22% vs 2022 (€ 487,226) Favourable step	€ 668,142 Gross margin 2024: € 668,142 ▲ 12% vs 2023 (€ 596,023) Favourable step	€ 609,302 Gross margin 2025: € 609,302 ▼ 9% vs 2024 (€ 668,142) Unfavourable step	▼ 9%
Profit after taxes	€ 89,704 Profit after taxes 2022: € 89,704 First fiscal year in the series	€ 117,812 Profit after taxes 2023: € 117,812 ▲ 31% vs 2022 (€ 89,704) Favourable step	€ 159,015 Profit after taxes 2024: € 159,015 ▲ 35% vs 2023 (€ 117,812) Favourable step	€ 132,324 Profit after taxes 2025: € 132,324 ▼ 17% vs 2024 (€ 159,015) Unfavourable step	▼ 17%
Equity	€ 250,711 Equity 2022: € 250,711 First fiscal year in the series	€ 118,523 Equity 2023: € 118,523 ▼ 53% vs 2022 (€ 250,711) Unfavourable step	€ 227,538 Equity 2024: € 227,538 ▲ 92% vs 2023 (€ 118,523) Favourable step	€ 284,862 Equity 2025: € 284,862 ▲ 25% vs 2024 (€ 227,538) Favourable step	▲ 25%
Total debts	€ 595,166 Total debts 2022: € 595,166 First fiscal year in the series	€ 1,069,417 Total debts 2023: € 1,069,417 ▲ 80% vs 2022 (€ 595,166) Unfavourable step	€ 813,701 Total debts 2024: € 813,701 ▼ 24% vs 2023 (€ 1,069,417) Favourable step	€ 860,290 Total debts 2025: € 860,290 ▲ 6% vs 2024 (€ 813,701) Unfavourable step	▲ 6%
Cash	€ 125,541 Cash 2022: € 125,541 First fiscal year in the series	€ 102,571 Cash 2023: € 102,571 ▼ 18% vs 2022 (€ 125,541) Unfavourable step	€ 143,857 Cash 2024: € 143,857 ▲ 40% vs 2023 (€ 102,571) Favourable step	€ 243,835 Cash 2025: € 243,835 ▲ 69% vs 2024 (€ 143,857) Favourable step	▲ 69%
Land & buildings	€ 134,027 Land & buildings 2022: € 134,027 First fiscal year in the series	€ 250,894 Land & buildings 2023: € 250,894 ▲ 87% vs 2022 (€ 134,027) Unchanged	€ 240,407 Land & buildings 2024: € 240,407 ▼ 4% vs 2023 (€ 250,894) Unchanged	€ 209,861 Land & buildings 2025: € 209,861 ▼ 13% vs 2024 (€ 240,407) Unchanged	▼ 13%
Retained profit	€ 188,711 Retained profit 2022: € 188,711 First fiscal year in the series	€ 56,523 Retained profit 2023: € 56,523 ▼ 70% vs 2022 (€ 188,711) Unfavourable step	€ 165,538 Retained profit 2024: € 165,538 ▲ 193% vs 2023 (€ 56,523) Favourable step	€ 222,862 Retained profit 2025: € 222,862 ▲ 35% vs 2024 (€ 165,538) Favourable step	▲ 35%
Dividend	€ 51,761 Dividend 2022: € 51,761 First fiscal year in the series	€ 250,000 Dividend 2023: € 250,000 ▲ € 198,239 vs 2022 (€ 51,761) Unchanged	€ 50,000 Dividend 2024: € 50,000 ▼ 80% vs 2023 (€ 250,000) Unchanged	€ 75,000 Dividend 2025: € 75,000 ▲ 50% vs 2024 (€ 50,000) Unchanged	▲ 50%
Bank debt	€ 211,835 Bank debt 2022: € 211,835 First fiscal year in the series	€ 330,027 Bank debt 2023: € 330,027 ▲ 56% vs 2022 (€ 211,835) Unfavourable step	€ 146,497 Bank debt 2024: € 146,497 ▼ 56% vs 2023 (€ 330,027) Favourable step	€ 93,568 Bank debt 2025: € 93,568 ▼ 36% vs 2024 (€ 146,497) Favourable step	▼ 36%
Balance sheet total	€ 845,877 Balance sheet total 2022: € 845,877 First fiscal year in the series	€ 1,187,940 Balance sheet total 2023: € 1,187,940 ▲ 40% vs 2022 (€ 845,877) Unchanged	€ 1,041,239 Balance sheet total 2024: € 1,041,239 ▼ 12% vs 2023 (€ 1,187,940) Unchanged	€ 1,145,152 Balance sheet total 2025: € 1,145,152 ▲ 10% vs 2024 (€ 1,041,239) Unchanged	▲ 10%
Employees (FTE)	8.4 Employees (FTE) 2022: 8.4 First fiscal year in the series	9 Employees (FTE) 2023: 9 ▲ 0.6 vs 2022 (8.4) Unchanged	9.2 Employees (FTE) 2024: 9.2 ▲ 0.2 vs 2023 (9) Unchanged	8.6 Employees (FTE) 2025: 8.6 ▼ 0.6 vs 2024 (9.2) Unchanged	▼ 0.6

Key figures of PHARDEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARDEN?

What happened at PHARDEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 3, 2026 New annual accounts for financial year 2025: profit of € 132,324 (▼ 17% vs 2024). Source: NBB ↗
Mar 23, 1993 New establishment in Bièvre. KBO
Feb 18, 1993 Start of the company according to the CBE. KBO

In short

From € 89,704 profit in 2022 to € 132,324 profit in 2025.

Paid € 181,842 in corporate taxes since 2022.

Best year ever: 2024, with € 159,015 profit.

On average € 70,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

DR PHARMA 100%

The stake of DR PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARDEN

Behind PHARDEN are CYRILLE REGNIER and Dr Pharma. The shares are held by DR PHARMA (100%).

Directors

According to the 2025 annual accounts

CYRILLE REGNIER

Andere functie

Also active at: DR PHARMA

Dr Pharma

Director

Shareholders

DR PHARMA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Bouillon 17

5555 Bièvre

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

DR PHARMA same network

€ 120,788 gross margin · 2025

Cabinet Médical Camille Dumonceaux

€ 128,237 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0449.472.066

VAT number

BE 0449.472.066

Registered office

Rue de Bouillon 17, 5555 Bièvre

Names & denominations

PHARDEN

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

18 February 1993

Peppol

Active · Active since 15 Dec 2025

Contact

[email protected]

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARDEN

Warning lights

Financials

What happened to PHARDEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions